These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 3142716)

  • 1. Prevention of heterotopic ossification by nonsteroid antiinflammatory drugs after total hip arthroplasty.
    Sodemann B; Persson PE; Nilsson OS
    Clin Orthop Relat Res; 1988 Dec; (237):158-63. PubMed ID: 3142716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periarticular heterotopic ossification after total hip arthroplasty for primary coxarthrosis.
    Sodemann B; Persson PE; Nilsson OS
    Clin Orthop Relat Res; 1988 Dec; (237):150-7. PubMed ID: 3142715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of periarticular heterotopic ossification following total hip arthroplasty. Clinical experience with indomethacin and ibuprofen.
    Sodemann B; Persson PE; Nilsson OS
    Arch Orthop Trauma Surg (1978); 1988; 107(6):329-33. PubMed ID: 3149179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total hip arthroplasty. The role of antiinflammatory medications in the prevention of heterotopic ossification.
    Kjaersgaard-Andersen P; Schmidt SA
    Clin Orthop Relat Res; 1991 Feb; (263):78-86. PubMed ID: 1899640
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No effective prophylaxis of heterotopic ossification with short-term ibuprofen.
    Koorevaar CT; Hu HP; Lemmens A; van Kampen A
    Arch Orthop Trauma Surg; 1999; 119(3-4):183-5. PubMed ID: 10392515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterotopic bone formation after noncemented total hip arthroplasty. Location of ectopic bone and the influence of postoperative antiinflammatory treatment.
    Kjaersgaard-Andersen P; Sletgård J; Gjerløff C; Lund F
    Clin Orthop Relat Res; 1990 Mar; (252):156-62. PubMed ID: 2105869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term treatment with nonsteroidal antiinflammatory medications to prevent heterotopic bone formation after total hip arthroplasty. A preliminary report.
    Kjaersgaard-Andersen P; Ritter MA
    Clin Orthop Relat Res; 1992 Jun; (279):157-62. PubMed ID: 1600651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do non-steroidal anti-inflammatory drugs cause endoprosthetic loosening? A 10-year follow-up of a randomized trial on ibuprofen for prevention of heterotopic ossification after hip arthroplasty.
    Persson PE; Nilsson OS; Berggren AM
    Acta Orthop; 2005 Dec; 76(6):735-40. PubMed ID: 16470423
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Incidence of anterior intertrochanteric ossifications after total hip arthroplasty--a retrospective long-term follow-up study].
    Metzner G; Lindner B; Neumann D; Dorn U
    Z Orthop Unfall; 2010 Mar; 148(2):174-9. PubMed ID: 20178081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naproxen in the prevention of heterotopic ossification after total hip replacement.
    Vielpeau C; Joubert JM; Hulet C
    Clin Orthop Relat Res; 1999 Dec; (369):279-88. PubMed ID: 10611883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of periarticular ossification following endoprosthetic hip replacement using postoperative irradiation].
    Sauer R; Seegenschmiedt MH; Goldmann A; Beck H; Andreas P
    Strahlenther Onkol; 1992 Feb; 168(2):89-99. PubMed ID: 1542851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty.
    Legenstein R; Bösch P; Ungersböck A
    Arch Orthop Trauma Surg; 2003 Apr; 123(2-3):91-4. PubMed ID: 12664317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of heterotopic ossification in high-risk patients with total hip arthroplasty: the experience of a combined therapeutic protocol.
    Pakos EE; Pitouli EJ; Tsekeris PG; Papathanasopoulou V; Stafilas K; Xenakis TH
    Int Orthop; 2006 Apr; 30(2):79-83. PubMed ID: 16482442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Eight days of naproxen therapy can prevent heterotopic ossification after total hip alloplasty].
    Gebuhr PH; Wilbek H; Soelberg M
    Ugeskr Laeger; 1996 Feb; 158(8):1076-8. PubMed ID: 8638341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology and treatment of periarticular heterotopic ossification after total hip replacement.
    Sodemann B; Persson PE; Nilsson O
    Rev Chir Orthop Reparatrice Appar Mot; 1988; 74 Suppl 2():329-30. PubMed ID: 3148171
    [No Abstract]   [Full Text] [Related]  

  • 16. Nonsteroidal anti-inflammatory drugs for prevention of heterotopic ossification after total hip arthroplasty.
    Nilsson OS
    Semin Arthroplasty; 1992 Jul; 3(3):172-7. PubMed ID: 10147776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of heterotopic ossification with irradiation after total hip arthroplasty. Radiation therapy with a single dose of eight hundred centigray administered to a limited field.
    Pellegrini VD; Konski AA; Gastel JA; Rubin P; Evarts CM
    J Bone Joint Surg Am; 1992 Feb; 74(2):186-200. PubMed ID: 1541613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventive effects of ibuprofen on periarticular heterotopic ossification after total hip arthroplasty. A randomized double-blind prospective study of treatment time.
    Persson PE; Sodemann B; Nilsson OS
    Acta Orthop Scand; 1998 Apr; 69(2):111-5. PubMed ID: 9602764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of radiation dose in a combined therapeutic protocol for the prevention of heterotopic ossification after total hip replacement.
    Pakos EE; Tsekeris PG; Paschos NK; Pitouli EJ; Motsis EK; Xenakis TA
    J BUON; 2010; 15(1):74-8. PubMed ID: 20414931
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Prospective study on the prevention of heterotopic ossification after total hip replacement. Non-steroidal anti-inflammatory agents versus radiation therapy].
    Kölbl O; Flentje M; Eulert J; Barthel T; Knelles D; Kraus U
    Strahlenther Onkol; 1997 Dec; 173(12):677-82. PubMed ID: 9454352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.